TY - JOUR
T1 - Management of plateau iris syndrome with cataract extraction and endoscopic cyclophotocoagulation
AU - Hollander, David A.
AU - Pennesi, Mark E.
AU - Alvarado, Jorge A.
N1 - Funding Information:
Supported by major grants from the National Eye Institute of the National Institutes of Health (1R01EY021509), the Thomas J. Long Foundation, the McBean Family Foundation, the Joan Leidy Foundation, That Man May See, Inc., the Department of Ophthalmology at the University of California San Francisco, and Research to Prevent Blindness (JAA). We also thank the following patients for their contributions: Mary A. Anderson, Mr. and Mrs. Sanford R. Robertson, Earl Skeel, June M. Carros and Doris M. Raffetto, Diane S. Heiman, and Burton L. Wise.
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Plateau iris configuration describes an anatomic abnormality in which large or anteriorly positioned pars plicata push the iris root forward, thereby narrowing the anterior chamber angle. Plateau iris syndrome (PIS) is diagnosed if the angle remains occludable, either spontaneously or pharmacologically, after iridotomy. PIS has traditionally been treated with chronic pilocarpine or laser peripheral iridoplasty. A series of 9 eyes of 6 patients with PIS, diagnosed by dark room provocative testing and ultrasound biomicroscopy (UBM) following iridotomy, underwent cataract extraction and endoscopic cyclophotocoagulation (ECP). The ciliary body was treated for a median of 180° (range of 120–360°). Post-ECP, the angles in areas treated with ECP were open with corresponding flattened ciliary processes on UBM, while the angles remained occludable in quadrants untreated by ECP despite lens extraction. The mean follow-up time post-ECP was 73.7 ± 34 months (range 11–122 months). The mean IOP was reduced from a baseline of 25.2 ± 10.9 mm Hg on 3.4 ± 1.0 IOP lowering medications to a mean IOP of 17.1 ± 5.3 mm Hg (p < 0.05) on 1.9 ± 1.5, (p < 0.01) medications at last visit. There were no cases of chronic inflammation, eye pain, decreased vision, retinal detachment, or hypotony. Lens extraction and ECP offers an alternative treatment option for patients with PIS, which may directly address the underlying anatomic abnormality leading to angle closure in PIS.
AB - Plateau iris configuration describes an anatomic abnormality in which large or anteriorly positioned pars plicata push the iris root forward, thereby narrowing the anterior chamber angle. Plateau iris syndrome (PIS) is diagnosed if the angle remains occludable, either spontaneously or pharmacologically, after iridotomy. PIS has traditionally been treated with chronic pilocarpine or laser peripheral iridoplasty. A series of 9 eyes of 6 patients with PIS, diagnosed by dark room provocative testing and ultrasound biomicroscopy (UBM) following iridotomy, underwent cataract extraction and endoscopic cyclophotocoagulation (ECP). The ciliary body was treated for a median of 180° (range of 120–360°). Post-ECP, the angles in areas treated with ECP were open with corresponding flattened ciliary processes on UBM, while the angles remained occludable in quadrants untreated by ECP despite lens extraction. The mean follow-up time post-ECP was 73.7 ± 34 months (range 11–122 months). The mean IOP was reduced from a baseline of 25.2 ± 10.9 mm Hg on 3.4 ± 1.0 IOP lowering medications to a mean IOP of 17.1 ± 5.3 mm Hg (p < 0.05) on 1.9 ± 1.5, (p < 0.01) medications at last visit. There were no cases of chronic inflammation, eye pain, decreased vision, retinal detachment, or hypotony. Lens extraction and ECP offers an alternative treatment option for patients with PIS, which may directly address the underlying anatomic abnormality leading to angle closure in PIS.
KW - Angle closure
KW - ECP
KW - Endoscopic cyclophotocoagulation
KW - Endoscopic cycloplasty
KW - Glaucoma
KW - Iridoplasty
KW - Plateau iris
KW - Plateau iris configuration
KW - Plateau iris syndrome
KW - Ultrasound biomicroscopy
UR - http://www.scopus.com/inward/record.url?scp=85012932556&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85012932556&partnerID=8YFLogxK
U2 - 10.1016/j.exer.2016.07.018
DO - 10.1016/j.exer.2016.07.018
M3 - Review article
C2 - 27475976
AN - SCOPUS:85012932556
SN - 0014-4835
VL - 158
SP - 190
EP - 194
JO - Experimental Eye Research
JF - Experimental Eye Research
ER -